Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Lifted by Wolff Wiese Magana LLC

Wolff Wiese Magana LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,194 shares of the medical equipment provider’s stock after purchasing an additional 49 shares during the period. Wolff Wiese Magana LLC’s holdings in Intuitive Surgical were worth $623,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter worth $33,000. Mark Sheptoff Financial Planning LLC acquired a new position in Intuitive Surgical in the second quarter worth $37,000. Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the third quarter valued at $38,000. Finally, DT Investment Partners LLC raised its holdings in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 3.6 %

Shares of NASDAQ:ISRG opened at $558.46 on Wednesday. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $559.94. The business has a fifty day simple moving average of $537.05 and a 200 day simple moving average of $496.50. The firm has a market cap of $198.91 billion, a price-to-earnings ratio of 89.78, a P/E/G ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. BTIG Research boosted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.